Phase II study of belzutifan plus cabozantinib for previously treated advanced renal cell carcinoma (RCC): Update from cohort 2 of LITESPARK-003

D. F. McDermott,T. K. Choueiri,S. Tykodi,J. Merchan,A. Roy, R. Perini, D. Vickery, T. Bauer

ANNALS OF ONCOLOGY(2022)

引用 4|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要